Immunotherapy Drugs system Market by drug type (monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors), by application (Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Immunotherapy Drugs system Market by drug type (monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors), by application (Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1156 | Pages: 174 | November 2016 | Region: Global


The Global Immunotherapy Drugs Market is estimated to be USD 68.4 billion and is projected to reach USD 112.69 billion by 2021 with a significant CAGR of 10.5%. The need for immunotherapy drugs is on the rise with the increase in number of autoimmune diseases and cancer incidences. This coupled with the lesser side effects of Immunotherapy drugs is expected to result in a positive outlook of the market in the review period.

Immunotherapy is a type of cancer treatment that enhances the innate powers of immune system. Immunotherapy treatment involves using the patient’s own immune system to help and fight cancer. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. These properties of immune system to fight abnormal cells gives immunotherapy drugs the chance of successfully fighting against the diseases like cancer, infection, respiratory and autoimmune disorders.

Rising prevalence of auto immune and cancer has led to technological innovations and helped in developing immunotherapy drugs which are more effective than the prevailing drugs. Factors such as rising disease incidences with changing demographics, emergence of biosimilars, higher efficacy with lower side effects, development of new drugs and reduction in overall time for drug development are driving the growth of the market. However, factors such as high cost of treatment and limited accessibility are restraining the growth of the market.

The global market for Immunotherapy drugs is segmented based on the type of drugs and by application. Based on the type of drugs, the market is classified as monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors. By application, the market is segmented as Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma. Based on geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.

The key players in the Immunotherapy Drugs market include Merck, Roche, Eli Lilly, Amgen, Novartis, Celgene, AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline PLC and Seattle Genetics.

  1. Introduction

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

  1. Research Methodology

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

  1. Overview

                3.1 Executive Summary                

                3.2 Key Inferences                         

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

  1. Market Segmentation

                5.1 By Drug Type                             

                                5.1.1 Monoclonal Antibodies     

                                5.1.2 Interferons             

                                5.1.3 Interleukins            

                                5.1.4 Vaccines  

                                5.1.5 Checkpoint Inhibitors         

                5.2 By Application                           

                                5.2.1 Blood Cancer         

                                5.2.2 Cervical Cancer     

                                5.2.3 Breast Cancer        

                                5.2.4 Glioblastoma         

                                5.2.5 Lung Cancer           

                                5.2.6 Gastric Cancer       

                                5.2.7 Prostate Cancer    

                                5.2.8 Melanoma              

  1. Geographical Analysis

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                                6.3.6 Australia  

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Mexico     

                                6.4.4 Argentina

                                6.4.5 Rest of Latin America         

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

  1. Pipeline Product Analysis

                7.1 Overview                                    

                7.2 Pipeline Development Landscape                                     

                7.3 Molecular Targets in the Pipeline                                     

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                 

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.               

  1. Strategic Analysis

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

  1. Market Leaders' Analysis

                9.1 Eli Lilly                           

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Merck                           

                9.3 Roche                           

                9.4 Amgen                         

                9.5 Novartis                       

                9.6 Celgene                       

                9.7 AstraZeneca               

                9.8 Bristol Myers Squibb                              

                9.9 GlaxoSmithKline PLC                              

                9.10 Seattle Genetics                    

  1. Competitive Landscape

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

  1. Market Outlook and Investment Opportunities

Appendix                                           

  1. a) List of Tables
  2. b) List of Figures
  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Immunotherapy Drugs Market By Region, From 2016-2021 (USD Billion)
  2. Global Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  3. Global Monoclonal Antibodies Market By Region, From 2016-2021 (USD Billion)
  4. Global Interferons Market By Region, From 2016-2021 (USD Billion)
  5. Global Interleukins Market By Region, From 2016-2021 (USD Billion)
  6. Global Vaccines Market By Region, From 2016-2021 (USD Billion)
  7. Global Checkpoint Inhibitors Market By Region, From 2016-2021 (USD Billion)
  8. Global Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  9. Global Blood Cancer Market By Region, From 2016-2021 (USD Billion)
  10. Global Cervical Cancer Market By Region, From 2016-2021 (USD Billion)
  11. Global Breast Cancer Market By Region, From 2016-2021 (USD Billion)
  12. Global Glioblastoma Market By Region, From 2016-2021 (USD Billion)
  13. Global Lung Cancer Market By Region, From 2016-2021 (USD Billion)
  14. Global Gastric Cancer Market By Region, From 2016-2021 (USD Billion)
  15. Global Prostate Cancer Market By Region, From 2016-2021 (USD Billion)
  16. Global Melanoma Market By Region, From 2016-2021 (USD Billion)
  17. North America Immunotherapy Drugs Market By Region, From 2016-2021 (USD Billion)
  18. North America Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  19. North America Monoclonal Antibodies Market By Region, From 2016-2021 (USD Billion)
  20. North America Interferons Market By Region, From 2016-2021 (USD Billion)
  21. North America Interleukins Market By Region, From 2016-2021 (USD Billion)
  22. North America Vaccines Market By Region, From 2016-2021 (USD Billion)
  23. North America Checkpoint Inhibitors Market By Region, From 2016-2021 (USD Billion)
  24. North America Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  25. North America Blood Cancer Market By Region, From 2016-2021 (USD Billion)
  26. North America Cervical Cancer Market By Region, From 2016-2021 (USD Billion)
  27. North America Breast Cancer Market By Region, From 2016-2021 (USD Billion)
  28. North America Glioblastoma Market By Region, From 2016-2021 (USD Billion)
  29. North America Lung Cancer Market By Region, From 2016-2021 (USD Billion)
  30. North America Gastric Cancer Market By Region, From 2016-2021 (USD Billion)
  31. North America Prostate Cancer Market By Region, From 2016-2021 (USD Billion)
  32. North America Melanoma Market By Region, From 2016-2021 (USD Billion)
  33. Europe Immunotherapy Drugs Market By Region, From 2016-2021 (USD Billion)
  34. Europe Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  35. Europe Monoclonal Antibodies Market By Region, From 2016-2021 (USD Billion)
  36. Europe Interferons Market By Region, From 2016-2021 (USD Billion)
  37. Europe Interleukins Market By Region, From 2016-2021 (USD Billion)
  38. Europe Vaccines Market By Region, From 2016-2021 (USD Billion)
  39. Europe Checkpoint Inhibitors Market By Region, From 2016-2021 (USD Billion)
  40. Europe Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  41. Europe Blood Cancer Market By Region, From 2016-2021 (USD Billion)
  42. Europe Cervical Cancer Market By Region, From 2016-2021 (USD Billion)
  43. Europe Breast Cancer Market By Region, From 2016-2021 (USD Billion)
  44. Europe Glioblastoma Market By Region, From 2016-2021 (USD Billion)
  45. Europe Lung Cancer Market By Region, From 2016-2021 (USD Billion)
  46. Europe Gastric Cancer Market By Region, From 2016-2021 (USD Billion)
  47. Europe Prostate Cancer Market By Region, From 2016-2021 (USD Billion)
  48. Europe Melanoma Market By Region, From 2016-2021 (USD Billion)
  49. Asia-Pacific Immunotherapy Drugs Market By Region, From 2016-2021 (USD Billion)
  50. Asia-Pacific Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  51. Asia-Pacific Monoclonal Antibodies Market By Region, From 2016-2021 (USD Billion)
  52. Asia-Pacific Interferons Market By Region, From 2016-2021 (USD Billion)
  53. Asia-Pacific Interleukins Market By Region, From 2016-2021 (USD Billion)
  54. Asia-Pacific Vaccines Market By Region, From 2016-2021 (USD Billion)
  55. Asia-Pacific Checkpoint Inhibitors Market By Region, From 2016-2021 (USD Billion)
  56. Asia-Pacific Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  57. Asia-Pacific Blood Cancer Market By Region, From 2016-2021 (USD Billion)
  58. Asia-Pacific Cervical Cancer Market By Region, From 2016-2021 (USD Billion)
  59. Asia-Pacific Breast Cancer Market By Region, From 2016-2021 (USD Billion)
  60. Asia-Pacific Glioblastoma Market By Region, From 2016-2021 (USD Billion)
  61. Asia-Pacific Lung Cancer Market By Region, From 2016-2021 (USD Billion)
  62. Asia-Pacific Gastric Cancer Market By Region, From 2016-2021 (USD Billion)
  63. Asia-Pacific Prostate Cancer Market By Region, From 2016-2021 (USD Billion)
  64. Asia-Pacific Melanoma Market By Region, From 2016-2021 (USD Billion)
  65. Latin America Immunotherapy Drugs Market By Region, From 2016-2021 (USD Billion)
  66. Latin America Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  67. Latin America Monoclonal Antibodies Market By Region, From 2016-2021 (USD Billion)
  68. Latin America Interferons Market By Region, From 2016-2021 (USD Billion)
  69. Latin America Interleukins Market By Region, From 2016-2021 (USD Billion)
  70. Latin America Vaccines Market By Region, From 2016-2021 (USD Billion)
  71. Latin America Checkpoint Inhibitors Market By Region, From 2016-2021 (USD Billion)
  72. Latin America Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  73. Latin America Blood Cancer Market By Region, From 2016-2021 (USD Billion)
  74. Latin America Cervical Cancer Market By Region, From 2016-2021 (USD Billion)
  75. Latin America Breast Cancer Market By Region, From 2016-2021 (USD Billion)
  76. Latin America Glioblastoma Market By Region, From 2016-2021 (USD Billion)
  77. Latin America Lung Cancer Market By Region, From 2016-2021 (USD Billion)
  78. Latin America Gastric Cancer Market By Region, From 2016-2021 (USD Billion)
  79. Latin America Prostate Cancer Market By Region, From 2016-2021 (USD Billion)
  80. Latin America Melanoma Market By Region, From 2016-2021 (USD Billion)
  81. Middle East & Africa Immunotherapy Drugs Market By Region, From 2016-2021 (USD Billion)
  82. Middle East & Africa Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  83. Middle East & Africa Monoclonal Antibodies Market By Region, From 2016-2021 (USD Billion)
  84. Middle East & Africa Interferons Market By Region, From 2016-2021 (USD Billion)
  85. Middle East & Africa Interleukins Market By Region, From 2016-2021 (USD Billion)
  86. Middle East & Africa Vaccines Market By Region, From 2016-2021 (USD Billion)
  87. Middle East & Africa Checkpoint Inhibitors Market By Region, From 2016-2021 (USD Billion)
  88. Middle East & Africa Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  89. Middle East & Africa Blood Cancer Market By Region, From 2016-2021 (USD Billion)
  90. Middle East & Africa Cervical Cancer Market By Region, From 2016-2021 (USD Billion)
  91. Middle East & Africa Breast Cancer Market By Region, From 2016-2021 (USD Billion)
  92. Middle East & Africa Glioblastoma Market By Region, From 2016-2021 (USD Billion)
  93. Middle East & Africa Lung Cancer Market By Region, From 2016-2021 (USD Billion)
  94. Middle East & Africa Gastric Cancer Market By Region, From 2016-2021 (USD Billion)
  95. Middle East & Africa Prostate Cancer Market By Region, From 2016-2021 (USD Billion)
  96. Middle East & Africa Melanoma Market By Region, From 2016-2021 (USD Billion)
Middle East And Africa Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ...
Latin America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Asia Pacific Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnol...
Europe Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Co...
North America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies...
Middle East And Africa Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics),...
Latin America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Asia Pacific Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User ...
Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospi...
North America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Cl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.